Digital Content 
NEWS #PharmaBuzz
25 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/blue-earth-therapeutics-snmmi-presentation-of-results-from-lutetium-177lu-rhpsma-10-1-injection-phase-1-clinical-trial-302490153.html
01 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/blue-earth-therapeutics-initiates-phase-2-clinical-trial-evaluating-the-efficacy-and-safety-of-lutetium-177lu-rhpsma-10-1-injection-in-metastatic-castrate-resistant-prostate-cancer-302441668.html
20 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/eckert--ziegler-and-atomvie-global-radiopharma-sign-a-global-agreement-for-lutetium-177-supply-302406500.html
13 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/blue-earth-therapeutics-reports-key-results-from-lutetium-177lu-rhpsma-10-1-injection-phase-1-clinical-trial-302400601.html
24 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/24/2952191/0/en/Curium-Announces-the-Official-Opening-its-New-Netherlands-Facility-for-the-Production-of-Lutetium-177-a-Game-Changer-Therapy-Isotope-for-Cancer-Patients-Worldwide.html
09 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/en/news-release/2024/07/09/2910486/0/en/Curium-Submits-New-Drug-Application-for-Lutetium-Lu-177-Dotatate-Injection.html
Share 